First report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertension

Michael Böhm, Felix Mahfoud, Christian Ukena, Uta C Hoppe, Krzysztof Narkiewicz, Manuela Negoita, Luis Ruilope, Markus P Schlaich, Roland E Schmieder, Robert Whitbourn, Bryan Williams, Uwe Zeymer, Andreas Zirlik, Giuseppe Mancia,

Research output: Contribution to journalArticleAcademicpeer-review


UNLABELLED: This study aimed to assess the safety and effectiveness of renal denervation using the Symplicity system in real-world patients with uncontrolled hypertension (NCT01534299). The Global SYMPLICITY Registry is a prospective, open-label, multicenter registry. Office and 24-hour ambulatory blood pressures (BPs) were measured. Change from baseline to 6 months was analyzed for all patients and for subgroups based on baseline office systolic BP, diabetic status, and renal function; a cohort with severe hypertension (office systolic pressure, ≥160 mm Hg; 24-hour systolic pressure, ≥135 mm Hg; and ≥3 antihypertensive medication classes) was also included. The analysis included protocol-defined safety events. Six-month outcomes for 998 patients, including 323 in the severe hypertension cohort, are reported. Mean baseline office systolic BP was 163.5±24.0 mm Hg for all patients and 179.3±16.5 mm Hg for the severe cohort; the corresponding baseline 24-hour mean systolic BPs were 151.5±17.0 and 159.0±15.6 mm Hg. At 6 months, the changes in office and 24-hour systolic BPs were -11.6±25.3 and -6.6±18.0 mm Hg for all patients (P<0.001 for both) and -20.3±22.8 and -8.9±16.9 mm Hg for those with severe hypertension (P<0.001 for both). Renal denervation was associated with low rates of adverse events. After the procedure through 6 months, there was 1 new renal artery stenosis >70% and 5 cases of hospitalization for a hypertensive emergency. In clinical practice, renal denervation resulted in significant reductions in office and 24-hour BPs with a favorable safety profile. Greater BP-lowering effects occurred in patients with higher baseline pressures.

CLINICAL TRIAL REGISTRATION: URL: Unique identifier: NCT01534299.

Original languageEnglish
Pages (from-to)766-774
Number of pages9
Issue number4
Publication statusPublished - Apr 2015


  • Blood Pressure
  • Blood Pressure Monitoring, Ambulatory
  • Female
  • Follow-Up Studies
  • Humans
  • Hypertension
  • Male
  • Middle Aged
  • Prospective Studies
  • Registries
  • Renal Artery
  • Sympathectomy
  • Sympathetic Nervous System
  • Time Factors
  • Treatment Outcome


Dive into the research topics of 'First report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertension'. Together they form a unique fingerprint.

Cite this